Physician profile
Sameh Girgis
NPI 1942614565
$56,632.78
in general payments reported to CMS, 2019-2025
12 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,473 · 2020: $503 · 2021: $17K · 2022: $8,719 · 2023: $2,908 · 2024: $9,461 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,840.93 |
| Food and Beverage | $12,246.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,178.17 | 2019-2025 | Farapulse, General - Therapies, Emblem Mri S-Icd |
| Medtronic, INC. | $14,915.31 | 2022-2025 | Micra, Evera Mri Xt Dr Surescan, Selectsecure |
| Abbott Laboratories | $8,749.25 | 2019-2025 | Ensite, Aveir, Ensite Precision |
| Biosense Webster, INC. | $4,744.04 | 2020-2025 | Carto 3, Nuvision Ice Catheter |
| Medical Device Business Services, INC. | $3,519.53 | 2019-2024 | Carto 3 |
| Biotronik INC. | $2,330.09 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $78.00 | 2020 | |
| Abiomed | $38.42 | 2025 | |
| Stryker Corporation | $22.82 | 2025 | Artix Mt |
| Pfizer INC. | $20.97 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.66 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.52 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Girgis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.